TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 150 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q4 2016. The put-call ratio across all filers is 2.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $255,000 | -21.1% | 3,547 | -19.1% | 0.00% | – |
| Q1 2021 | $323,000 | +18.8% | 4,384 | -1.3% | 0.00% | – |
| Q1 2020 | $272,000 | -76.6% | 4,440 | -66.4% | 0.00% | -100.0% |
| Q4 2019 | $1,163,000 | +301.0% | 13,226 | +290.1% | 0.00% | +100.0% |
| Q2 2019 | $290,000 | +21.3% | 3,390 | +20.1% | 0.00% | 0.0% |
| Q4 2018 | $239,000 | -36.4% | 2,822 | -21.3% | 0.00% | 0.0% |
| Q4 2017 | $376,000 | +4.4% | 3,588 | +10.2% | 0.00% | -50.0% |
| Q3 2016 | $360,000 | -66.7% | 3,256 | -56.1% | 0.00% | -60.0% |
| Q2 2016 | $1,081,000 | +89.3% | 7,423 | +86.2% | 0.01% | +66.7% |
| Q1 2016 | $571,000 | -58.9% | 3,987 | -55.8% | 0.00% | -78.6% |
| Q3 2014 | $1,389,000 | +125.5% | 9,028 | +105.7% | 0.01% | +75.0% |
| Q2 2014 | $616,000 | -38.9% | 4,389 | -51.7% | 0.01% | -27.3% |
| Q1 2014 | $1,008,000 | – | 9,081 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 78,905 | $8,306,000 | 7.65% |
| FORT, L.P. | 157,584 | $16,589,000 | 4.68% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 808,200 | $85,079,000 | 4.39% |
| Strategic Global Advisors, LLC | 81,432 | $8,572,000 | 3.18% |
| Prince Street Capital Management LLC | 48,700 | $5,127,000 | 1.62% |
| Analyst IMS Investment Management Services Ltd. | 31,438 | $3,309,000 | 1.45% |
| Freestone Capital Holdings, LLC | 84,900 | $8,937,000 | 0.77% |
| RPG Investment Advisory, LLC | 17,227 | $1,813,000 | 0.61% |
| CLINTON GROUP INC | 46,370 | $4,881,000 | 0.28% |
| USA FINANCIAL FORMULAS | 10,786 | $1,135,000 | 0.28% |